Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter Financial Results

NEXT STORY
Ziopharm Oncology Receives Positive Opinion for Orphan Drug Designation from the European Medicines Agency for Ad-RTS-hIL-12 plus Veledimex for the Treatment of Glioma
PREV STORY
ADMA Biologics Reports Second Quarter and First Half 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cellectar Biosciences Reports Cohort Four Data and Partial Response in Relapsed or Refractory Multiple Myeloma Patient Treated with CLR 131

MADISON, Wis., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, ...

author_avatar
NASDAQ Market News

BeyondSpring to Host Quarterly Operational Update Conference Call on November 9, 2017

NEW YORK, Nov. 02, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical ...

author_avatar
NASDAQ Market News

Insight Unites with Southwest Human Development on IoT Challenge to Help Children with Disabilities

High school STEM assistive technology competition connects young innovators with experts in smart devices ...

author_avatar
NASDAQ Market News